1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Arginyl-glycyl-aspartic acid (RGD) containing nanostructured lipid carrier co-loaded with Doxorubicin and Sildenafil Citrate enhanced anti-cancer effects and overcomes drug resistance

      , , , , ,
      Process Biochemistry
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Process Biochemistry
          Process Biochemistry
          Elsevier BV
          13595113
          June 2019
          June 2019
          Article
          10.1016/j.procbio.2019.06.013
          0e87c041-6dc7-4215-a710-7df28a4950e6
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article